OTTAWA, ON, Feb. 21, 2025 /PRNewswire/ - Esphera SynBio Inc. will be featured in an upcoming episode of Advancements, a television program hosted by Ted Danson and broadcast on the Bloomberg cable and ...

As I explained in my first overview article in this series, LanzaTech is an industrial chemicals business. But to describe it as merely another commodity chemicals producer misses the point entirely.

Ginkgo Bioworks, a synthetic biology company with technology that programs cells in the same way that coders program computers, is going public in a merger deal that values the firm at $15 billion.

"SynBio," which is short for synthetic biology, is a concept many may not have heard of before. But analysts at Putnam Investments say it's worthwhile for investors to commit it to memory. "We believe ...

Synthetic biology powerhouse Ginkgo Bioworks said today it will become a public company through a $17.5 billion merger with a special purpose acquisition company (SPAC) that is expected to provide up ...

Synthetic biology company Esphera SynBio announced the closing of a $2 million seed financing round. The funding builds on the company’s advanced R&D activities and proceeds are directed at ...

ROI strategies focus on CRISPR, automated DNA synthesis, R&D alliances, integrated platforms and scalable biomanufacturing to speed commercialization and diversify revenue.Dublin, Oct. 09, 2026 (GLOBE ...

Synthetic biology is the design and construction of new biological parts, devices, and systems, and the re-design of existing, natural biological systems for useful purposes. Existing approaches for ...

In Washington, DC, Xian-en Zhang, Director General, Basic Research Department, China Ministry of Science and Technology, stated that the People’s Republic of China is seeking to position itself as a ...

"SynBio," which is short for synthetic biology, is a concept many may not have heard of before. But analysts at Putnam Investments say it's worthwhile for investors to commit it to memory. "We believe ...